LOGWOOD LONGLEAF PINE

LOGWOOD (Haematoxylum campechianum L.) ++

Activities (Logwood) :
Antibacterial (1; WOI); Antiinflammatory (f; PH2); Antimelanic (f; PH2); Antiseptic (1; PH2; WOI); Astringent (1; EFS; PH2; WOI); Depurative (f; JFM); Hemostat (1; EFS); Tonic (f; JFM; WOI).

Indications (Logwood) :
Atony (f; WOI); Bacteria (1; WOI); Bleeding (1; EFS; JFM; PH2); Cancer (f; WOI); Diarrhea (f; JFM; PH2); Dysentery (f; JFM); Gangrene (f; WOI); Infection (1; PH2; WOI); Inflammation (f; PH2); Leukorrhea (f; WOI); Mycobacteria (1; WOI).

Dosages (Logwood) :
Doses equivalent to 1 g drug (HHB; PH2).

Contraindications, Interactions, and Side Effects (Logwood) :
Not covered (AHP). “Hazards and/or side effects not recorded for proper therapeutic dosages” (PH2). Internal hematoxylin in animals may induce anuria, coma, hyperthermia, vomiting, and possibly death (PH2).


LONGLEAF PINE (Pinus palustris Miller) ++

Synonyms:
P. australis F. Michx., P. longifolia Salisb.

KOM entries apply to turpentine of this species. This species was treated as aetheroleum, rather intermixed under scotch pine (see below), by the Herbal PDR (PHR).

Activities (Longleaf Pine) :
Antiseptic (2; KOM); Hemostat (f; FAD); Rubefacient (f; FAD).

Indications (Longleaf Pine) :
Bleeding (f; FAD); Boil (f; PNC; resin); Bronchosis (2; KOM; turpentine) (f; PNC; resin); Cold (2; PHR); Colic (f; FAD); Cough (2; PHR); Diarrhea (f; FAD); Fever (2; PHR); Infection (2; PHR); Muscle Stiffness (f; PNC; terpentine); Neuralgia (2; KOM; turpentine); Odontorrhagia (f; FAD); Pharyngosis (2; PHR); Rheumatism (2; FAD; KOM; PNC; turpentine) (f; PNC; resin); Ringworm (f; PNC; resin); Sore (f; PNC); Stomatosis (2; PHR); Tumor (f; FAD); Ulcer (f; PNC; resin).

Dosages (Longleaf Pine)
Commission E suggests several drops turpentine in hot water for inhalation therapy (KOM). Otherwise for topical application only.

Contraindications, Interactions, and Side Effects (Longleaf Pine) :
Commission E reports contraindications for EO: whooping cough; adverse effects: local irritation, exacerbation of bronchospasms (AEH). Though approving pure turpentine for “Chronic disease of the bronchii with heavy secretion” (which I translate to bronchosis), Commission E contraindicates for acute inflammation of the respiratory tract. Inhaled turpentine may reduce bronchial secretion (KOM). Even topical application to too much surface area may damage the CNS and kidneys (KOM). Turpentine is a counterirritant and rubefacient. Though also taken internally, turpentine might best be relegated to topical uses, if any.